Florian P. Huber, LL.M.
Florian specialises in energy law and the regulated industries. He advises at all market levels, in particular on unbundling, remuneration and access issues in the energy sector.
In addition to European law aspects, he advises on all regulatory issues in energy law, in particular on grid connection and access, on grid fee regulation, on subsidies and privileges under the German Renewable Energy Act (Erneuerbare-Energien-Gesetz, EEG) and the German Combined Heat and Power Act (Kraft-Wärme-Kopplungsgesetz, KWKG), and on concession fees.
A particular focus of Florian’s work is advising energy-intensive industries on all aspects of energy law and renewable energies. In addition, Florian regularly accompanies domestic and foreign clients in proceedings before the German and European regulatory authorities and courts. Before joining Pinsent Masons, Florian worked in energy law and litigation for other leading international law firms in San Francisco and Düsseldorf.
Senior Practice Development Lawyer
Tadeusz is responsible for a range of practice development activities within our Competition, EU & Trade team, supporting the team’s EU and UK competition law work. This includes delivering training, monitoring legal developments, sharing knowledge, developing best practices and resources, and facilitating innovation.
Tom specialises in obtaining authorisation for major infrastructure schemes with a particular emphasis in the energy and transport sectors.
Theresa is part of the German Intellectual Property team with focus on the Life Science sector as well as other high-tech industries. She advises national and international clients on all aspects of Intellectual Property and Unfair Competition Law including the draft and negotiation of licence agreements.
Tamsin is a Senior Associate in Pinsent Masons’ European IP practice, specialising in contentious patent issues. She advises a diverse portfolio of clients on patent matters related to technologies in a variety of industries including pharmaceuticals (small molecules and biosimilars) and medical devices.